Our findings provide exploratory evidence connecting metallomics with FFAs and cardiometabolic diseases, suggesting FFAs as potential biomarkers for metal exposure and cardiometabolic diseases prevention.
Mei et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: